Press Releases

Press Releases

Today Edgemont Capital Partners, a leading independent investment banking firm providing merger and acquisition advisory services to healthcare companies, announced that it acted as exclusive financial advisor to SCYNEXIS, Inc. in the sale of its contract research and development services business to Avista Pharma Solutions. The deal was announced on…

Press Releases

Array BioPharma Inc. will report financial results for the fourth quarter and full year of fiscal 2015 and hold a conference call to discuss those results on Monday, August 3, 2015.  Ron Squarer, Chief Executive Officer will lead the call. Date:           Monday, August 3, 2015 Time:           9:00 a.m. Eastern Time…

Press Releases

CTI BioPharma Corp. today announced the appointment of Bruce J. Seeley as Executive Vice President and Chief Commercial Officer, reporting to James Bianco, M.D., CTI BioPharma's President and Chief Executive Officer. Seeley joins CTI BioPharma effective today and will serve on the executive leadership team, assuming responsibility for CTI BioPharma's…

Press Releases

In the run up to our 2nd Annual Drug Discovery USA Congress 2015, we spoke with Matthew Wagoner a discovery safety specialist from AstraZeneca, a confirmed speaker at the congress where he will talk about Bromodomain And ExtraTerminal (BET) Domain Inhibitors Induce A Loss Of Intestinal Stem Cells And Villous…

Press Releases

Approaching our well-established 13th Annual Pharmaceutical IT Congress, we sat down with Nigel Hughes, Director Integrative Healthcare Informatics, Janssen Pharma R&D and Marc Berger, Vice President, Real World Data and Analytics, Pfizer, to talk about the pharmaceutical IT industry. Nigel Hughes will be speaking on Day 2 of the 13th…

Monday, Jul 27, 2015
Press Releases

Indian pharmaceutical companies are on the radar of FDA’s observations. The pace of ever –evolving standards have led to decry of this industry. State of ‘import alerts’, export bans and warning letters (Form 483) over the last two years have unexpectedly increased. And these were issued mainly during surprise audits…

Press Releases

Charles River Laboratories International, Inc. announced today that it has completed the previously announced acquisition of Celsis International Ltd. for $212 million in cash, subject to certain post-closing working capital adjustments. The acquisition complements Charles River Endotoxin and Microbial Detection’s (EMD) position as a leading provider of rapid endotoxin testing…

Press Releases

Commonwealth Laboratories, Inc. announced today that it has reached an agreement with Valeant Pharmaceuticals International, Inc. (“Valeant”) for the acquisition by Valeant of Commonwealth’s business in the United States (U.S.) and Canada. This includes rights to IBSchek™, a breakthrough blood test designed to help physicians quickly and reliably diagnose irritable…

Press Releases

Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced the European Medicines Agency (EMA) has accepted for review a marketing authorization application (MAA) for grazoprevir/elbasvir (100mg/50mg), an investigational, once-daily, single-tablet combination therapy for the treatment of adult patients with chronic hepatitis C (HCV) genotypes (GT) 1,…

Press Releases

Eagle Pharmaceuticals, Inc. today announced that the 505(b)(2) New Drug Application (NDA) for its novel ready-to-use bivalirudin product (“RTU bivalirudin”) has been accepted for filing by the U.S. Food and Drug Administration (FDA). This 505(b)(2) NDA requests FDA approval of Eagle’s RTU bivalirudin product for the treatment of patients: (1)…